Search

everythinglearnresearchcommunity

for

Search:↓

Migrants from certain regions had a higher risk of COVID-19 than Spaniards.

GLP-1 RAs help with diabetes and skin issues but can cause skin reactions and surgery challenges.

Women with PCOS are at higher risk for gum disease, and managing shared risk factors can help both conditions.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Male-pattern baldness is weakly linked to some heart disease risk factors but not a strong indicator for heart disease.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

Bald men may have higher heart disease risk.

Premature hair greying may indicate a higher risk of metabolic problems.

Baldness may indicate higher heart disease risk in men.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

People with alopecia areata have a higher risk of stroke.

Water near Abakaliki mines has high toxic metal levels, posing health risks.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

Spironolactone might lower the chance of getting rosacea.

WomenCare helps predict PCOD risk in women to encourage early medical consultation.

GLP-1RA therapy may increase the risk of hair loss.

Cosmetics can contain harmful chemicals that may cause health issues.

Physical activity, height, and smoking affect prostate cancer risk.

Higher cholesterol levels increase aggressive prostate cancer risk.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Age, stress, and anger increase the risk of hair fall.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Many survivors of critical illness, especially those with sepsis, experience hair loss.